gms | German Medical Science

62nd Annual Meeting of the German Society of Neurosurgery (DGNC)
Joint Meeting with the Polish Society of Neurosurgeons (PNCH)

German Society of Neurosurgery (DGNC)

7 - 11 May 2011, Hamburg

Preconditioning with intramuscular injection of VEGF in the rat double subarachnoid hemorrhage model: effects on cerebral vasospasm and neoangiogenesis

Meeting Abstract

  • S. Eicker - Klinik für Neurochirurgie, Heinrich-Heine-Universität, Düsseldorf
  • M. Hoppe - Klinik für Neurochirurgie, Heinrich-Heine-Universität, Düsseldorf
  • S. Macht - Institut für Neuroradiologie, Heinrich-Heine-Universität, Düsseldorf
  • H.J. Steiger - Klinik für Neurochirurgie, Heinrich-Heine-Universität, Düsseldorf
  • D. Hänggi - Klinik für Neurochirurgie, Heinrich-Heine-Universität, Düsseldorf

Deutsche Gesellschaft für Neurochirurgie. Polnische Gesellschaft für Neurochirurgen. 62. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit der Polnischen Gesellschaft für Neurochirurgen (PNCH). Hamburg, 07.-11.05.2011. Düsseldorf: German Medical Science GMS Publishing House; 2011. DocP 049

DOI: 10.3205/11dgnc270, URN: urn:nbn:de:0183-11dgnc2707

Published: April 28, 2011

© 2011 Eicker et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.


Outline

Text

Objective: endothelial growth factor (VEGF) stimulating angiogenesis was shown to be a potential novel therapeutic approach for the treatment of ischemic vascular disease. The goal of the present study was to examine whether gene delivery of VEGF164 can provide a useful approach in the treatment of vasospasm-induced ischemic lesions after experimental subarachnoid hemorrhage (SAH).

Methods: Four groups of male rats (n=80) received intramuscular injections with a plasmid containing VEGF164, VEGF-free plasmid or saline three times at 7-day intervals. Seven days after the last gene transfer, vasospasm was induced by double blood injection into the cisterna magna. Vasospasm was analyzed 5 days later by means of digital subtraction angiography investigating large vessels (macroperfusion) and small vessels (microperfusion). Morphological examinations of brain parenchyma were performed using hematoxylin and eosin (HE) staining and immunohistochemical staining of VEGF and CD31.

Results: A total of 44 brains were successfully analyzed (20 in the gene-transferred group, 14 in the control group, 8 in the saline group and 4 in the saline group without SAH). Significant vasospasm (macro- and microperfusion) was induced in all hemorrhage groups compared to the sham-operated group (p<0.05). No significant difference in macroperfusion was detected in the VEGF164-treated group compared to other SAH groups. Analyzing microperfusion and results of HE and CD31 staining a trend to an activated neoangiogenesis with reduced ischemic lesions was documented.

Conclusions: The present study demonstrates reduced vasospasm with acceleration of microperfusion and reduced ischemic lesions in animals treated with VEGF injection prior to induced SAH.